Fate Therapeutics Receives Allowance of First US Patent for Induced ... PR-CANADA.net (press release) In April of last year, under a research collaboration with Fate Therapeutics and TSRI, Dr. Ding and his team of scientists became the first group to publish ... and more »
Read more...
Related Stories:
-
Fate Therapeutics Receives Allowance of First U.S. Patent for Induced ... - PR Newswire (press release)
Fate Therapeutics Receives Allowance of First U.S. Patent for Induced ...PR Newswire (press release)In April of last year, under a research collaboration...
2010-02-04 07:02:22 -
Fate Therapeutics and Stemgent Launch Catalyst: A Unique Industry ... - PR Newswire (press release)
Fate Therapeutics and Stemgent Launch Catalyst: A Unique Industry ...PR Newswire (press release), NYBecause iPS cells can differentiate into any cell type, iPS...
2009-04-23 11:02:44
-
Hard To Treat Diseases (HTDS.PK) Scientists report results that are ... - PR-CANADA.net (press release)
Hard To Treat Diseases (HTDS.PK) Scientists report results that are ...PR-CANADA.net (press release)Discover for yourself why and how USA based small businesses...
2010-06-07 09:22:32 -
Regulus Therapeutics Presents New Pre-clinical Data on microRNA Therapeutics ... - MarketWatch (press release)
Regulus Therapeutics Presents New Pre-clinical Data on microRNA Therapeutics ...MarketWatch (press release)In 2008, Regulus entered into a major alliance with GlaxoSmithKline to...
2010-04-15 07:06:42 -
Festival Eureka! - Press release - Canada NewsWire (press release)
Festival Eureka! - Press releaseCanada NewsWire (press release), CanadaDiscover the technological innovations of the Québec aerospace sector with the Aéro Montréal team and...
2009-06-03 10:33:22 -
ExonHit Therapeutics - 2007 Financial Results - PR Newswire (press release)
ExonHit Therapeutics - 2007 Financial ResultsPR Newswire (press release), NY - 40 minutes agoExonHit also has a strategic partnership with Allergan, to discover and...
2008-03-05 11:18:10 -
Alnylam, Mount Sinai scientists discover svRNAs that ... - News-Medical.Net
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today the publication of new research findings in the journal Proceedings...
2010-06-02 01:51:00 -
Government Supports Science Promotion for Youth Across Canada - Market Wire (press release)
Government Supports Science Promotion for Youth Across CanadaMarket Wire (press release)"It's great to see such a wide range of groups from across...
2009-05-15 01:04:34